1. Home
  2. NKTR vs KNDI Comparison

NKTR vs KNDI Comparison

Compare NKTR & KNDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTR
  • KNDI
  • Stock Information
  • Founded
  • NKTR 1990
  • KNDI 2002
  • Country
  • NKTR United States
  • KNDI China
  • Employees
  • NKTR N/A
  • KNDI N/A
  • Industry
  • NKTR Biotechnology: Pharmaceutical Preparations
  • KNDI Auto Manufacturing
  • Sector
  • NKTR Health Care
  • KNDI Consumer Discretionary
  • Exchange
  • NKTR Nasdaq
  • KNDI Nasdaq
  • Market Cap
  • NKTR 108.3M
  • KNDI 96.3M
  • IPO Year
  • NKTR 1994
  • KNDI N/A
  • Fundamental
  • Price
  • NKTR $24.73
  • KNDI $1.27
  • Analyst Decision
  • NKTR Strong Buy
  • KNDI
  • Analyst Count
  • NKTR 6
  • KNDI 0
  • Target Price
  • NKTR $81.67
  • KNDI N/A
  • AVG Volume (30 Days)
  • NKTR 4.9M
  • KNDI 134.9K
  • Earning Date
  • NKTR 08-07-2025
  • KNDI 08-15-2025
  • Dividend Yield
  • NKTR N/A
  • KNDI N/A
  • EPS Growth
  • NKTR N/A
  • KNDI N/A
  • EPS
  • NKTR N/A
  • KNDI N/A
  • Revenue
  • NKTR $87,248,000.00
  • KNDI $127,569,613.00
  • Revenue This Year
  • NKTR N/A
  • KNDI N/A
  • Revenue Next Year
  • NKTR N/A
  • KNDI N/A
  • P/E Ratio
  • NKTR N/A
  • KNDI N/A
  • Revenue Growth
  • NKTR N/A
  • KNDI 3.21
  • 52 Week Low
  • NKTR $6.48
  • KNDI $0.89
  • 52 Week High
  • NKTR $37.38
  • KNDI $2.07
  • Technical
  • Relative Strength Index (RSI)
  • NKTR 67.01
  • KNDI 63.81
  • Support Level
  • NKTR $21.87
  • KNDI $1.09
  • Resistance Level
  • NKTR $26.89
  • KNDI $1.30
  • Average True Range (ATR)
  • NKTR 2.11
  • KNDI 0.06
  • MACD
  • NKTR -0.20
  • KNDI 0.01
  • Stochastic Oscillator
  • NKTR 76.31
  • KNDI 86.36

About NKTR Nektar Therapeutics

Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.

About KNDI Kandi Technologies Group Inc

Kandi Technologies Group Inc is engaged in developing, manufacturing, and commercializing fully electric vehicle products and related technologies. Its products mainly consist of EV parts, EV products, and off-road vehicles, including All-Terrain Vehicles (ATVs), UTVs, go-karts, electric scooters, electric self-balancing scooters, and associated parts, and Lithium-ion cells, etc. The company generates maximum revenue from the sale of Off-road vehicles and associated parts. Geographically, it derives maximum revenue from the United States and other countries, followed by China.

Share on Social Networks: